Clinical Trial: Prevalence of Cachexia in Patients Undergoing Chemotherapy

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Prevalence and Impact of Cachexia in Cancer Patients Undergoing Chemotherapy

Brief Summary: Cachexia and low nutritional intake are a common phenomena in cancer patients undergoing chemotherapy. The purpose of this study is to assess prevalence of cachexia and low nutritional intake and the impact on quality of life, fatigue and mortality in patients undergoing chemotherapy. Furthermore interactions between these parameters, tumor disease and chemotherapy, respectively.

Detailed Summary:
Sponsor: Charite University, Berlin, Germany

Current Primary Outcome: Nutritional intake [ Time Frame: 1 day ]

Nutritional intake will be assessed by 24h-recall, which will be analysed with regard to macronutritients


Original Primary Outcome: Nutritional intake [ Time Frame: 1 day ]

Current Secondary Outcome:

  • Cachexia [ Time Frame: 1 day ]
    Cachexia will be evaluated using the patient-generated Subjective Global Assessment.
  • Quality of life and fatigue [ Time Frame: 1 day ]
    EORTC QLQ C-30 will be used to assess quality of life and additionally cancer-related fatigue will be evaluated using Brief Fatigue Inventory.
  • Mortality [ Time Frame: 6 months ]
    Mortality will be assesses via telephone or consultation of the local death register


Original Secondary Outcome:

  • Cachexia [ Time Frame: 1 day ]
  • Quality of life and fatigue [ Time Frame: 1 day ]
  • Mortality [ Time Frame: 6 months ]


Information By: Charite University, Berlin, Germany

Dates:
Date Received: September 6, 2013
Date Started: April 2010
Date Completion:
Last Updated: September 11, 2013
Last Verified: September 2013